Focus Areas
Advancing translational medical technologies from material science to clinical impact.
OVERVIEW
Bridging Science. Engineering. Clinical Impact.
The BTEC Center integrates biomaterials engineering, surface modification, and device design with preclinical and clinical translation to develop next – generation solutions for critical medical challenges.

Biomaterials Engineering
Designing and optimizing advanced materials and surface chemistries to enhance biocompatibility and function in the body.

Clinical Translation
Drang technologies from bench to bedside through precincal modes, coltaboration, and regulatory pathway alignment.

Device Innovation
Engineering devices that improve performance, reduce complications, and elevate the standard of patient care.
KEY FOCUS AREAS
Our Research. Real-World Impact.
Extracorporeal Membrane Oxygenation (ECMO)
Our work on ECMO circuits centers on developing hemocompatible materials, surface chemistries, and device designs that reduce thrombosis and infection while minimizing reliance on systemic anticoagulation.
- Hemocompatible surfaces
- Infection mitigation
- Reduced thrombosis
- Heparin-free alternatives
Catheterization
Our catheter research focuses on engineering advanced biomaterials, surface coatings, and device designs that reduce thrombosis and infection while maintaining mechanical performance and clinical usability
- Advanced biomaterials & coatings
- Enhanced mechanical performance
- Reduced thrombosis & infection
- Improved blood-material interaction
Wound Healing
Our wound healing work focuses on advanced biomaterials and device-enabled therapies that reduce microbial bioburden and limit excessive inflammation in acute and chronic wounds.
- Antimicrobial & anti-inflammatory solutions
- Support for acute & chronic wound care
- Tissue regeneration & repair
- Translational, patient-centered technologies

Collaborating for a Healthier Future
We collaborate across disciplines and industries to accelerate innovation and deliver meaningful solutions that improve patient outcomes.